How GLP-1s tanked and reshaped the medtech stock market | Mass Device

Sep 26, 2024

medtech stocks 2023

Promising clinical trial results on glucagon-like peptide 1 agonists (GLP-1s) created a seismic shift in the medtech stock market.

Source: How GLP-1s tanked and reshaped the medtech stock market | Mass Device

Hire with SEC


Schedule a free consultation today to experience our innovative, industry-leading executive search and engineer recruiting hiring process firsthand.

"*" indicates required fields

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Pin It on Pinterest